1 unchanged sentence
Market Information
−Removed: Our common stock is traded on the Nasdaq Global Market under the symbol “CDNA” since July 22, 2014.
+Added: Our common stock has been trading on the Nasdaq Global Market under the symbol “CDNA” since July 22, 2014.
The daily market activity and closing prices of our common stock can be found at www.nasdaq.com.
7 unchanged sentences
Stock Performance Graph
−Removed: The following stock performance graph and related information shall not be deemed “soliciting material” or to be “filed” with the SEC, nor shall such information be incorporated by reference into any future filing under the Securities Act or Exchange Act, except to the extent that we specifically incorporate it by reference into such filing.
+Added: The following stock performance graph and related information shall not be deemed “soliciting material” or to be “filed” with the SEC, nor shall such information be incorporated by reference into any future filing under the Securities Act of 1934, as amended, or the Exchange Act, except to the extent that we specifically incorporate it by reference into such filing.
The following stock performance graph compares total stockholder returns for CareDx, Inc.
−Removed: from July 22, 2014 (the date of our initial public offering) through December 31, 2019 against the Nasdaq Market Composite Index and Nasdaq Biotech Index, assuming a $100 investment made on July 22, 2014.
+Added: from December 31, 2015 through December 31, 2020 against the Nasdaq Market Composite Index and Nasdaq Biotech Index, assuming a $100 investment made on December 31, 2015.
Each of the two comparative measures of cumulative total return assumes reinvestment of dividends.
16 unchanged sentences
SELECTED FINANCIAL DATA
−Removed: The following selected historical financial data should be read in conjunction with “Item 7.
−Removed: Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K.
−Removed: The selected balance sheet data at December 31, 2019 and 2018 and the selected statements of operations data for each of the years ended December 31, 2019, 2018 and 2017 have been derived from our audited consolidated financial statements that are included elsewhere in this Annual Report on Form 10-K.
−Removed: The selected balance sheet data at December 31, 2017, 2016 and 2015 and the selected statements of operations data for each of the years ended December 31, 2016 and 2015 were derived from our audited consolidated financial statements that are not included in this Annual Report on Form 10-K.
−Removed: The financial data included in this report are historical and are not necessarily indicative of results to be expected in any future period.
−Removed: Statements of Operations Data:
−Removed: Year Ended December 31,
−Removed: 2019 2018 2017 2016 2015
−Removed: (In thousands, except share and per share data)
−Removed: Testing services revenue $ 104,550 $ 60,300 $ 33,106 $ 29,680 $ 27,881
−Removed: Product revenue 18,279 15,674 14,634 10,715 —
−Removed: Digital and other revenue 4,239 595 584 236 263
−Removed: Total revenue 127,068 76,569 48,324 40,631 28,144
−Removed: Cost of revenue 45,455 32,987 21,371 21,122 10,273
−Removed: Gross profit 81,613 43,582 26,953 19,509 17,871
−Removed: Operating expenses:
−Removed: Research and development 30,711 14,514 12,388 12,385 9,333
−Removed: Sales and marketing 38,894 21,670 12,808 11,166 8,349
−Removed: General and administrative 36,540 22,976 20,093 20,269 12,121
−Removed: Goodwill impairment — — 1,958 13,021 —
−Removed: Total operating expenses 106,145 59,160 47,247 56,841 29,803
−Removed: Loss from operations (24,532) (15,578) (20,294) (37,332) (11,932)
−Removed: Other income (expense):
−Removed: Interest income (expense), net 985 (3,701) (5,863) (1,860) (1,587)
−Removed: Debt extinguishment expenses — (5,780) (459) — —
−Removed: Change in estimated fair value of common stock warrant and derivative liabilities 319 (22,978) (29,622) (250) —
−Removed: Other expense, net (719) (178) (1,031) (1,920) (188)
−Removed: Total other income (expense) 585 (32,637) (36,975) (4,030) (1,775)
−Removed: Loss before income taxes (23,947) (48,215) (57,269) (41,362) (13,707)
−Removed: Income tax benefit 1,979 1,434 1,709 1,606 —
−Removed: Net loss (21,968) (46,781) (55,560) (39,756) (13,707)
−Removed: Net loss attributable to noncontrolling
−Removed: interest — (25) (91) (287) —
−Removed: Net loss attributable to CareDx, Inc.
−Removed: $ (21,968) $ (46,756) $ (55,469) $ (39,469) $ (13,707)
−Removed: Net loss per share:
−Removed: Basic $ (0.52) $ (1.31) $ (2.38) $ (2.39) $ (1.16)
−Removed: Diluted $ (0.52) $ (1.31) $ (2.38) $ (2.39) $ (1.16)
−Removed: Shares used to compute net loss per share:
−Removed: Basic 42,151,617 35,638,956 23,332,503 16,496,911 11,860,885
−Removed: Diluted 42,151,617 35,638,956 23,332,503 16,496,911 11,860,885
−Removed: Balance Sheet Data:
−Removed: As of December 31,
−Removed: 2019 2018 2017 2016 2015
−Removed: (In thousands)
−Removed: Cash and cash equivalents $ 38,223 $ 64,616 $ 16,895 $ 17,258 $ 29,888
−Removed: Working capital 37,094 61,610 (16,139) (14,159) 24,210
−Removed: Total Assets 151,736 130,697 83,565 76,730 55,638
−Removed: Long term debt, net of current portion — — 18,338 1,098 12,887
−Removed: Accumulated (deficit) (333,813) (311,845) (268,022) (212,553) (173,084)
−Removed: Total CareDx, Inc.
−Removed: stockholders' equity (deficit) 99,000 95,928 (5,954) 19,761 29,494
+Added: Not required.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.